Svetislav Vukelja
Hematology & Oncology · Tyler, TXNPI 1851335442
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $730 of the $812 with a category attached, or 90.0%. It is spread thinly across 19 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $278 and has fallen 68.0% since, to $89 in 2025. That places this record below the midpoint for hematology & oncology clinicians in TX, where the typical reported total is $3,204.
Across 31 payments — averaging $26.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$178
- Johnson & Johnson$122
- Merck$80
- Lilly USA, LLC$69
- Jazz Pharmaceuticals Inc.$43
- Pharmacyclics LLC, An Abbvie Company$42
- plus $278 from 13 others
Across 25 payments — averaging $2857.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$60K
- Novartis$9K
- Pfizer$3K
What the payments were for
- Food & beverage$73090%
- Education$8110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $178 |
| Johnson & Johnson | 1 | $122 |
| Merck | 1 | $80 |
| Lilly USA, LLC | 1 | $69 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $42 |
| Pfizer | 3 | $39 |
| E.r. Squibb & Sons, L.L.C. | 1 | $33 |
| Gilead(2 entities) | 2 | $32 |
| GSK | 1 | $28 |
| Incyte Corporation | 1 | $22 |
| Bristol Myers Squibb | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Sanofi | 1 | $17 |
| Amgen | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $13 |
| Novartis | 1 | $12 |
| Array Biopharma Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$812 in reported general payments places this provider in the 25th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in Tyler
- Habte YimerTyler$934K
- Devesh PandyaHouston$1.8M
- Elias JabbourHouston$1.3M
- Asad DeanFort Worth$1.1M
- Edward PearsonDallas$900K
- Naval DaverHouston$853K
- Christopher MaiselDallas$713K
- Clifton LaymanEl Paso$645K
- Jorge Cortes-FrancoHouston$627K
- Timothy FenskeSan Antonio$626K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.